A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipati...
A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
About this item
Full title
Author / Creator
Publisher
Philadelphia, PA: Wolters Kluwer
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia, PA: Wolters Kluwer
More information
Scope and Contents
Contents
Prokinetic agents, specifically 5-hydroxytryptamine type 4 (5-HT4) receptor agonists, have been shown to provide relief in chronic idiopathic constipation (CIC). The first-generation 5-HT4 agonists were initially withdrawn from use owing to associations with serious cardiovascular (CV) events. This review summarizes CV safety data for prucalopride,...
Alternative Titles
Full title
A Review of the Cardiovascular Safety of Prucalopride in Patients With Chronic Idiopathic Constipation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_wolterskluwer_health_10_14309_ajg_0000000000002249
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_wolterskluwer_health_10_14309_ajg_0000000000002249
Other Identifiers
ISSN
0002-9270
E-ISSN
1572-0241
DOI
10.14309/ajg.0000000000002249
